# DNLI (Denali Therapeutics Inc.) - SEC EDGAR Financial Statements

> Denali Therapeutics Inc. reported $0 in revenue and a net loss of $314.4M for the fiscal year ended December 31, 2025.

- Canonical: https://convexityos.com/fundamentals/DNLI
- Markdown: https://convexityos.com/fundamentals/DNLI.md
- SEC CIK: 0001714899
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:19 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001714899&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | Dec 31, 2025 |
| Operating Income | FY 2025 | -$532.0M | Operating profit |
| Net Income | FY 2025 | -$314.4M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.64 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$450.0M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $516.2M | Total debt: $35.24M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $330.5M | $108.5M | $48.66M | $335.7M | $26.68M | $129.2M | $0 | $0 |
| Research & Development | $418.8M | $396.4M | $423.9M | $358.7M | $265.4M | $212.6M | $193.4M | $143.2M | $74.46M | $75.70M |
| Total Operating Expenses | $555.3M | $501.9M | $527.2M | $449.2M | $344.4M | $272.9M | $239.9M | $175.5M | $90.14M | $87.43M |
| **Operating Income** | -$555.3M | -$487.3M | -$196.7M | -$340.7M | -$295.8M | $62.72M | -$213.2M | -$46.37M | -$90.14M | -$87.43M |
| **EBITDA** | -$544.2M | -$479.5M | -$180.0M | -$330.4M | -$287.2M | $71.25M | -$205.2M | -$38.96M | -$87.06M | -$85.96M |
| Income Tax Expense | $102K | $68K | $30K | $21K | -$575K | $823K | -$351K | $0 | $0 | -- |
| **Net Income** | -$512.5M | -$422.8M | -$145.2M | -$326.0M | -$290.6M | $71.14M | -$197.6M | -$36.24M | -$88.19M | -$86.65M |
| Basic EPS | -$2.97 | -$2.57 | -$1.06 | -$2.60 | -$2.39 | $0.65 | -$2.07 | -$0.39 | -$5.89 | -$13.49 |
| **Diluted EPS** | -$2.97 | -$2.57 | -$1.06 | -$2.60 | -$2.39 | $0.63 | -$2.07 | -$0.39 | -$5.89 | -$13.49 |
| Basic Shares Outstanding | 172.6M | 164.5M | 137.4M | 125.5M | 121.5M | 109.0M | 95.6M | 92.6M | 15.0M | 6.4M |
| Diluted Shares Outstanding | 172.6M | 164.5M | 137.4M | 125.5M | 121.5M | 112.7M | 95.6M | 92.6M | 15.0M | 6.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $17.78M | $3.60M | -- | -- | $0 | $0 | -- | $0 |
| Cost of Revenue | $192K | $93K | -- | -- | $0 | $0 | -- | -- |
| **Gross Profit** | $17.59M | $3.51M | -- | -- | $0 | $0 | -- | -- |
| Research & Development | $106.1M | $97.02M | $103.8M | $97.91M | $102.0M | $102.7M | $116.2M | $99.79M |
| Selling, General & Admin | $37.48M | $36.28M | -- | -- | $35.48M | $32.27M | -- | -- |
| Total Operating Expenses | -- | -- | $137.4M | $137.4M | $137.4M | $135.0M | $145.6M | $129.8M |
| **Operating Income** | -$126.8M | -$130.5M | -$137.4M | -$137.4M | -$137.4M | -$135.0M | -$145.6M | -$129.8M |
| **EBITDA** | -$123.2M | -$127.0M | -$134.5M | -$134.5M | -$134.5M | -$131.9M | -$143.3M | -$128.0M |
| **Net Income** | $70.13M | -$127.6M | -$128.4M | -$128.5M | -$126.9M | -$124.1M | -$133.0M | -$114.8M |
| Basic EPS | $0.37 | -$0.68 | -$0.69 | -- | -$0.74 | -$0.72 | -$0.78 | -- |
| **Diluted EPS** | $0.37 | -$0.68 | -$0.69 | -- | -$0.74 | -$0.72 | -$0.78 | -- |
| Basic Shares Outstanding | 188.4M | 187.3M | 186.6M | -- | 172.4M | 171.4M | 171.2M | -- |
| Diluted Shares Outstanding | 192.1M | 187.3M | 186.6M | -- | 172.4M | 171.4M | 171.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $205.3M | $175.0M | $127.1M | $218.0M | $293.5M | $507.1M | $79.45M | $77.12M | $218.4M |
| Short-Term Investments | $662.6M | $657.4M | $907.4M | $1.12B | $571.9M | $962.6M | $335.9M | $387.2M | $187.9M |
| **Cash & Short-Term Investments** | $867.9M | $832.3M | $1.03B | $1.34B | $865.4M | $1.47B | $415.4M | $464.3M | $406.2M |
| Accounts Receivable, Net | $0 | -- | -- | -- | -- | $8.59M | -- | -- | -- |
| Inventory | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $900.7M | $864.4M | $1.06B | $1.37B | $897.2M | $1.50B | $430.0M | $480.8M | $409.6M |
| Property, Plant & Equipment, Net | $52.40M | $55.24M | $45.59M | $44.09M | $38.87M | $40.85M | $46.73M | $25.16M | $14.92M |
| Intangible Assets | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-Term Investments | $98.32M | $359.4M | $0 | $0 | $425.4M | $32.70M | $39.89M | $147.9M | $60.75M |
| Other Non-Current Assets | $25.94M | $24.74M | $18.14M | $13.40M | $11.87M | $2.46M | $2.66M | $8.11M | $1.44M |
| **Total Non-Current Assets** | $244.2M | $509.7M | $89.78M | $87.92M | $506.9M | $108.6M | $123.2M | $181.1M | $77.11M |
| **Total Assets** | $1.14B | $1.37B | $1.15B | $1.46B | $1.40B | $1.60B | $553.2M | $662.0M | $486.7M |
| Accounts Payable | $505K | $11.14M | $9.48M | $2.79M | $4.78M | $1.07M | $2.59M | $1.89M | $2.72M |
| Deferred Revenue (Current) | -- | -- | $0 | $290.1M | $27.91M | $19.91M | $18.74M | $11.43M | $0 |
| Other Current Liabilities | -- | -- | $0 | $4.39M | $53.16M | $47.15M | $24.02M | $19.47M | $63K |
| **Total Current Liabilities** | $98.35M | $102.2M | $77.98M | $363.9M | $378.2M | $71.70M | $45.34M | $32.79M | $14.16M |
| Deferred Revenue (Non-Current) | -- | -- | $0 | $479K | $3.40M | $23.32M | $43.75M | $57.35M | $0 |
| Other Non-Current Liabilities | -- | -- | $0 | $379K | $379K | $701K | $379K | $471K | $467K |
| **Total Non-Current Liabilities** | $32.74M | $42.29M | $44.98M | $53.89M | $63.63M | $382.1M | $113.0M | $82.35M | $6.76M |
| **Total Liabilities** | $131.1M | $144.5M | $123.0M | $417.8M | $441.9M | $453.7M | $158.3M | $115.1M | $20.93M |
| **Total Debt (incl. Leases)** | $42.29M | $54.32M | $52.24M | $60.35M | $64.01M | $68.86M | $72.53M | -- | -- |
| Common Stock | -- | -- | $1.71M | $1.69M | $1.55M | $1.53M | $1.29M | $1.27M | $1.20M |
| Retained Earnings | -$2.05B | -$1.54B | -$1.12B | -$971.0M | -$645.0M | -$354.4M | -$425.6M | -$227.9M | -$191.7M |
| Accumulated Other Comp. Income | $682K | $2.02M | $643K | -$6.89M | -$2.50M | -$245K | $350K | -$649K | -$368K |
| **Total Stockholders' Equity** | $1.01B | $1.23B | $1.03B | $1.04B | $962.3M | $1.15B | $394.9M | $546.8M | $465.8M |
| Total Equity | $1.01B | $1.23B | $1.03B | $1.04B | $962.3M | $1.15B | $394.9M | $546.8M | $465.8M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $102.9M | $201.5M | $387.6M | $205.3M | $90.96M | $141.2M | $56.95M | $175.0M |
| Short-Term Investments | $413.3M | $508.9M | $600.1M | $662.6M | $757.2M | $757.7M | $761.0M | $657.4M |
| **Cash & Short-Term Investments** | $516.2M | $710.5M | $987.7M | $867.9M | $848.2M | $899.0M | $817.9M | $832.3M |
| Accounts Receivable, Net | $18.88M | $3.93M | -- | $0 | -- | -- | -- | -- |
| Inventory | $26.27M | $4.14M | -- | $0 | -- | -- | -- | -- |
| **Total Current Assets** | $591.7M | $753.9M | $1.02B | $900.7M | $882.6M | $934.7M | $878.6M | $864.4M |
| Property, Plant & Equipment, Net | $47.91M | $49.93M | $51.73M | $52.40M | $53.73M | $58.72M | $57.77M | $55.24M |
| Intangible Assets | $34.50M | $35.25M | $36.00M | $0 | -- | -- | -- | -- |
| Long-Term Investments | $491.4M | $229.5M | $63.78M | $98.32M | $24.70M | $78.46M | $235.8M | $359.4M |
| Other Non-Current Assets | $29.15M | $25.82M | $26.22M | $25.94M | $25.11M | $22.97M | $26.93M | $24.74M |
| **Total Non-Current Assets** | $664.3M | $404.0M | $243.3M | $244.2M | $173.0M | $231.5M | $392.7M | $509.7M |
| **Total Assets** | $1.26B | $1.16B | $1.27B | $1.14B | $1.06B | $1.17B | $1.27B | $1.37B |
| Accounts Payable | $13.70M | $11.81M | $40.38M | $505K | $6.75M | $10.84M | $8.46M | $11.14M |
| **Total Current Liabilities** | $95.26M | $90.08M | $110.2M | $98.35M | $90.15M | $91.06M | $91.88M | $102.2M |
| **Total Non-Current Liabilities** | $234.4M | $232.7M | $229.8M | $32.74M | $39.28M | $48.13M | $56.78M | $42.29M |
| **Total Liabilities** | $329.6M | $322.8M | $339.9M | $131.1M | $129.4M | $139.2M | $148.7M | $144.5M |
| **Total Debt (incl. Leases)** | $35.24M | $37.69M | $40.05M | $42.29M | $44.48M | $47.97M | $51.57M | $54.32M |
| Retained Earnings | -$2.24B | -$2.31B | -$2.18B | -$2.05B | -$1.92B | -$1.80B | -$1.67B | -$1.54B |
| Accumulated Other Comp. Income | -$6.36M | -$1.97M | -$682K | $682K | $1.10M | $939K | $2.04M | $2.02M |
| **Total Stockholders' Equity** | $926.4M | $835.2M | $926.1M | $1.01B | $926.2M | $1.03B | $1.12B | $1.23B |
| Total Equity | $926.4M | $835.2M | $926.1M | $1.01B | $926.2M | $1.03B | $1.12B | $1.23B |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$512.5M | -$422.8M | -$145.2M | -$326.0M | -$290.6M | $71.14M | -$197.6M | -$36.24M | -$88.19M | -$86.65M |
| Depreciation & Amortization | $11.18M | $7.79M | $16.73M | $10.38M | $8.59M | $8.53M | $7.99M | $7.42M | $3.08M | $1.47M |
| Stock-Based Compensation | $99.63M | $102.9M | $108.1M | $99.85M | $85.25M | $50.35M | $38.38M | $18.79M | $4.41M | $2.95M |
| Change in Payables | -$7.52M | $1.44M | $2.43M | $2.27M | $3.71M | -$1.62M | $1.03M | -$526K | $207K | $161K |
| **Operating Cash Flow** | -$412.6M | -$347.7M | -$358.0M | -$244.7M | -$211.4M | $416.2M | -$151.6M | $50.12M | -$76.64M | -$71.91M |
| Capital Expenditure | -$9.50M | -$15.91M | -$12.94M | -$17.83M | -$8.50M | -$3.10M | -$17.92M | -$3.39M | -$2.88M | -$6.13M |
| **Free Cash Flow** | -$422.1M | -$363.6M | -$370.9M | -$262.5M | -$219.9M | $413.1M | -$169.5M | $46.72M | -$79.51M | -$78.04M |
| Purchases of Investments | -$441.3M | -$1.23B | -$1.81B | -$1.12B | -$1.42B | -$1.29B | -$369.7M | -$557.9M | -$179.8M | -$226.4M |
| **Investing Cash Flow** | $255.3M | -$88.76M | $249.3M | -$141.4M | -$21.63M | -$623.2M | $147.7M | -$287.4M | -$41.17M | -$219.0M |
| Common Stock Issued | -- | $0 | $0 | $296.2M | $0 | $193.9M | $0 | $0 | $265.6M | $0 |
| **Financing Cash Flow** | $189.2M | $484.3M | $17.82M | $310.7M | $19.35M | $634.7M | $6.19M | $97.02M | $296.3M | $300.5M |
| **Net Change in Cash** | $31.90M | $47.85M | -$90.86M | -$75.43M | -$213.7M | $427.7M | $2.33M | -$140.3M | $178.5M | $9.56M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $70.13M | -$127.6M | -$128.4M | -$128.5M | -$126.9M | -$124.1M | -$133.0M | -$114.8M |
| Depreciation & Amortization | $3.58M | $3.57M | $2.85M | $2.87M | $2.95M | $3.04M | $2.33M | $1.85M |
| Stock-Based Compensation | $22.86M | $22.91M | $23.09M | $23.95M | $25.14M | $25.39M | $25.16M | $25.08M |
| Change in Payables | $8.90M | $227K | $3.88M | -$3.41M | -$4.07M | $2.60M | -$2.64M | $1.29M |
| **Operating Cash Flow** | -$117.4M | -$97.00M | -$131.2M | -$98.54M | -$107.3M | -$75.30M | -$131.5M | -$83.72M |
| Capital Expenditure | -$1.01M | -$805K | -$2.47M | -$1.52M | $1.38M | -$4.28M | -$5.08M | -$5.09M |
| **Free Cash Flow** | -$118.5M | -$97.81M | -$133.7M | -$100.1M | -$105.9M | -$79.58M | -$136.5M | -$88.81M |
| Purchases of Investments | -$355.2M | -$271.5M | -$123.1M | -$252.7M | -$50.63M | $0 | -$137.9M | -$173.7M |
| **Investing Cash Flow** | $16.19M | -$104.1M | $94.46M | $20.77M | $57.83M | $157.9M | $18.75M | $172.2M |
| Common Stock Issued | $0 | $0 | $12.37M | -- | $0 | $0 | $0 | -$499.3M |
| **Financing Cash Flow** | $2.59M | $14.98M | $219.0M | $192.1M | -$778K | $1.62M | -$3.76M | -$4.17M |
| **Net Change in Cash** | -$98.66M | -$186.1M | $182.3M | $114.4M | -$50.24M | $84.26M | -$116.5M | $84.32M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -59.5% | -314.2% | -607.8% | 18.7% | -799.1% | -35.9% | -- | -- |
| **Net Profit Margin** | -- | -- | -43.9% | -300.6% | -597.2% | 21.2% | -740.7% | -28.1% | -- | -- |
| Return on Equity (ROE) | -50.6% | -34.4% | -14.1% | -31.3% | -30.2% | 6.2% | -50.0% | -6.6% | -18.9% | -- |
| Return on Assets (ROA) | -44.8% | -30.8% | -12.6% | -22.3% | -20.7% | 4.4% | -35.7% | -5.5% | -18.1% | -- |
| Current Ratio | 9.16x | 8.46x | 13.65x | 3.77x | 2.37x | 20.86x | 9.48x | 14.67x | 28.92x | -- |
| Quick Ratio | 9.16x | 8.14x | 13.27x | 3.67x | 2.29x | 20.62x | 9.16x | 14.16x | 28.68x | -- |
| Debt to Equity | 0.04x | 0.04x | 0.05x | 0.06x | 0.07x | 0.06x | 0.18x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -100.0% | +204.7% | +122.9% | -85.5% | +1158.2% | -79.3% | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -571.6% | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -508.5% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -467.7% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -150.8% | -- | -402.5% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -153.2% | -- | -462.8% | -- | -- | -- |
| 5Y Revenue / Share Growth | -100.0% | -100.0% | +72.5% | -- | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -554.8% | -- | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -33.9% | -61.2% | -54.9% | -50.6% | -53.8% | -46.6% | -40.4% | -34.4% |
| Return on Assets (ROA) | -25.0% | -44.2% | -40.1% | -44.8% | -47.2% | -41.1% | -35.7% | -30.8% |
| Current Ratio | 6.21x | 8.37x | 9.28x | 9.16x | 9.79x | 10.27x | 9.56x | 8.46x |
| Quick Ratio | 5.94x | 8.32x | 8.97x | 9.16x | 9.41x | 9.87x | 8.90x | 8.14x |
| Debt to Equity | 0.04x | 0.05x | 0.04x | 0.04x | 0.05x | 0.05x | 0.05x | 0.04x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
